{"id": "23786821-0496-4a97-9d82-053ec08ea8e7", "order": 1, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "ESMO Virtual Congress 2020 Opening ceremony", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-19T11:15:00.000000", "end_time": "2020-09-19T12:15:00.000000", "rangeorder": 103}
{"id": "fbc4e213-3cb3-4f1d-b71c-32808f28d8c1", "order": 2, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS13: Opening session", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-09-19T12:30:00.000000", "end_time": "2020-09-19T14:00:00.000000", "rangeorder": 104}
{"id": "f0631b5a-4726-458c-bf74-3228043809da", "order": 3, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS13: Quality and safety of cancer nursing", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-09-21T16:20:00.000000", "end_time": "2020-09-21T17:50:00.000000", "rangeorder": 105}
{"id": "a21facb4-7d8c-486b-8eae-1abe56991cfa", "order": 4, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS13: Immunotherapy and precision oncology: What do patients need?", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-09-20T12:30:00.000000", "end_time": "2020-09-20T14:00:00.000000", "rangeorder": 106}
{"id": "060df60f-564f-46c6-acee-281399cb1049", "order": 5, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS13: Age specific care: Adolescents and young adults (AYA)", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-09-21T12:30:00.000000", "end_time": "2020-09-21T14:00:00.000000", "rangeorder": 107}
{"id": "a7fab128-5666-4fb1-8824-f7c2012d7e14", "order": 6, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS13: Evolving roles in cancer nursing", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-09-19T14:25:00.000000", "end_time": "2020-09-19T15:55:00.000000", "rangeorder": 108}
{"id": "d2da4b12-d9e8-48c9-aeee-c2ff9eae5d92", "order": 7, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS13: Phase I clinical trials: What does this mean for our patients?", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-09-20T14:25:00.000000", "end_time": "2020-09-20T15:55:00.000000", "rangeorder": 109}
{"id": "7d4d541b-1422-44de-b347-8e7c78c04a7d", "order": 8, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS13: Age specific care in oncology: Geriatrics (in collaboration with SIOG)", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-09-21T14:25:00.000000", "end_time": "2020-09-21T15:55:00.000000", "rangeorder": 110}
{"id": "e995dd2b-68a4-409c-9139-35741e64296b", "order": 9, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS13: Supporting informal carers", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-09-20T16:20:00.000000", "end_time": "2020-09-20T17:50:00.000000", "rangeorder": 111}
{"id": "ecb413d5-7c2e-4d6a-b96a-8c2138ef3073", "order": 10, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "What is gender medicine and why do we need it in oncology?", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-21T11:15:00.000000", "end_time": "2020-09-21T12:15:00.000000", "rangeorder": 200}
{"id": "4f8150b5-08ea-4e93-b534-23288de72e67", "order": 11, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Connecting the dots: The ESMO vision on the value of cancer medicines", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-21T11:15:00.000000", "end_time": "2020-09-21T12:15:00.000000", "rangeorder": 201}
{"id": "2a3bb755-432a-4435-97be-3002ea516590", "order": 12, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Cancer policy: What it is and why you cannot work without it", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-20T11:15:00.000000", "end_time": "2020-09-20T12:15:00.000000", "rangeorder": 202}
{"id": "e64ad2f7-2b67-4141-9043-cf44995be1fb", "order": 13, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Non-metastatic NSCLC and other thoracic malignancies", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-19T12:30:00.000000", "end_time": "2020-09-19T14:10:00.000000", "rangeorder": 203}
{"id": "b514638d-e6e3-440b-b360-32008497bcf8", "order": 14, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Head & Neck cancer", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-19T12:30:00.000000", "end_time": "2020-09-19T14:10:00.000000", "rangeorder": 204}
{"id": "5841dd4e-5454-4a0d-b2e3-90b3c27d19ef", "order": 15, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - GI, colorectal", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-19T14:25:00.000000", "end_time": "2020-09-19T16:05:00.000000", "rangeorder": 205}
{"id": "c295c061-b988-4f22-8ec7-eddbeab50f9f", "order": 16, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Translational research", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-19T14:25:00.000000", "end_time": "2020-09-19T16:05:00.000000", "rangeorder": 206}
{"id": "83023409-088d-4273-8613-8295edc5c5a1", "order": 17, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - SARS-CoV-2 and cancer 1", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-19T14:25:00.000000", "end_time": "2020-09-19T16:05:00.000000", "rangeorder": 207}
{"id": "08a6b99a-d831-4cbc-9737-24f09c0d6c69", "order": 18, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Breast cancer, metastatic 1", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-19T16:20:00.000000", "end_time": "2020-09-19T18:00:00.000000", "rangeorder": 208}
{"id": "8986017a-31f5-4be9-ac11-57ad3c7a98c6", "order": 19, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Melanoma and other skin tumours", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-19T16:20:00.000000", "end_time": "2020-09-19T18:00:00.000000", "rangeorder": 209}
{"id": "d2824ebc-7c53-494f-a2a9-e6248264f5a5", "order": 20, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - GU, non prostate 1", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-19T16:20:00.000000", "end_time": "2020-09-19T18:00:00.000000", "rangeorder": 210}
{"id": "ece7729b-77ac-43a5-abd3-d34e4b1cb6cc", "order": 21, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - GI, non colorectal", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-20T12:30:00.000000", "end_time": "2020-09-20T14:10:00.000000", "rangeorder": 211}
{"id": "e582ed9c-7c75-4363-98b5-5fa29c721137", "order": 22, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - CNS tumours", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-20T12:30:00.000000", "end_time": "2020-09-20T14:10:00.000000", "rangeorder": 300}
{"id": "c281b6fe-6997-4ddc-be10-03b54f26abe0", "order": 23, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Breast cancer, early stage", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-20T12:30:00.000000", "end_time": "2020-09-20T14:10:00.000000", "rangeorder": 301}
{"id": "e9915884-bc51-4423-9973-f36f5e0d6cfa", "order": 24, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - NSCLC metastatic 1", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-20T14:25:00.000000", "end_time": "2020-09-20T16:05:00.000000", "rangeorder": 302}
{"id": "265deaee-f54b-4a98-b717-da8e40920f8d", "order": 25, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Investigational immunotherapy", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-20T14:25:00.000000", "end_time": "2020-09-20T16:05:00.000000", "rangeorder": 303}
{"id": "c06b6fd7-72a3-471f-8581-650224011d40", "order": 26, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - NETs", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-20T14:25:00.000000", "end_time": "2020-09-20T16:05:00.000000", "rangeorder": 304}
{"id": "2e1d1cbd-d13c-41eb-a5b3-8e67e45ea24b", "order": 27, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Sarcoma", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-20T16:20:00.000000", "end_time": "2020-09-20T18:00:00.000000", "rangeorder": 305}
{"id": "61fbd8c7-3d56-46bd-9fc2-bf19de3ab8a2", "order": 28, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - SARS-CoV-2 and cancer 2", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-20T16:20:00.000000", "end_time": "2020-09-20T18:00:00.000000", "rangeorder": 306}
{"id": "8914708c-d43e-4f33-9b35-2a7690f6deca", "order": 29, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Developmental therapeutics", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-20T16:20:00.000000", "end_time": "2020-09-20T18:00:00.000000", "rangeorder": 307}
{"id": "d88bf3e4-8ac5-4784-901d-dd0231179ec9", "order": 30, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Breast cancer, metastatic 2", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-21T12:30:00.000000", "end_time": "2020-09-21T14:10:00.000000", "rangeorder": 308}
{"id": "fddbd8f2-66a9-419c-8eb6-bc58e50dc5d2", "order": 31, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Supportive and palliative care", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-21T12:30:00.000000", "end_time": "2020-09-21T14:10:00.000000", "rangeorder": 309}
{"id": "405fbad3-318d-4f69-a135-bb8e38f9d32e", "order": 32, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - GU, prostate", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-21T14:25:00.000000", "end_time": "2020-09-21T16:05:00.000000", "rangeorder": 310}
{"id": "1263d2d5-b274-4814-9ad5-30a10a72e3c4", "order": 33, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Public Policy", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-21T14:25:00.000000", "end_time": "2020-09-21T16:05:00.000000", "rangeorder": 311}
{"id": "3cf8cf38-6924-4a6c-96af-4611245149bf", "order": 34, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - NSCLC metastatic 2", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-21T14:25:00.000000", "end_time": "2020-09-21T16:05:00.000000", "rangeorder": 400}
{"id": "fd6c7fb3-3116-4659-9d8f-a309b842713d", "order": 35, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Basic Science", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-21T16:20:00.000000", "end_time": "2020-09-21T18:00:00.000000", "rangeorder": 401}
{"id": "e4201703-2970-4be0-b6bd-e4732f62b0af", "order": 36, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - GU, non prostate 2", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-21T16:20:00.000000", "end_time": "2020-09-21T18:00:00.000000", "rangeorder": 402}
{"id": "134ec4fa-ad47-46cc-99f0-5b7d6fa09520", "order": 37, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Gynaecological cancers 2", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-21T16:20:00.000000", "end_time": "2020-09-21T18:00:00.000000", "rangeorder": 403}
{"id": "960a7b52-1efa-4d8f-8ffb-e64daa70fe48", "order": 38, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Presidential Symposium I", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-19T18:30:00.000000", "end_time": "2020-09-19T20:10:00.000000", "rangeorder": 404}
{"id": "da1fd7aa-fe53-4e1c-876d-9f380382fc0a", "order": 39, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Presidential Symposium III", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-21T18:30:00.000000", "end_time": "2020-09-21T20:10:00.000000", "rangeorder": 405}
{"id": "3ac72b02-738e-4816-abf7-6e354c6ca291", "order": 40, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Presidential Symposium II", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-09-20T18:30:00.000000", "end_time": "2020-09-20T20:25:00.000000", "rangeorder": 406}
{"id": "f3e90a0c-ad66-48da-9573-4bb1299197c0", "order": 41, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS13: Oncology care during Covid-19: How does it affect our patients", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-09-19T16:20:00.000000", "end_time": "2020-09-19T17:50:00.000000", "rangeorder": 407}
{"id": "5513ff57-35aa-4bc7-b0a6-2ace832fbe3e", "order": 42, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Women for Oncology Forum: Women in Science", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-20T11:15:00.000000", "end_time": "2020-09-20T12:15:00.000000", "rangeorder": 408}
{"id": "358f4bde-5ca7-4231-a7c8-efd2eb421076", "order": 43, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Challenges in the development and real-world use of the ESMO-MCBS", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-20T11:15:00.000000", "end_time": "2020-09-20T12:15:00.000000", "rangeorder": 409}
{"id": "be9d066c-cac2-4abd-91f2-ff2ae99e7206", "order": 44, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Proffered Paper - Gynaecological cancers 1", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-09-19T12:30:00.000000", "end_time": "2020-09-19T14:10:00.000000", "rangeorder": 410}
{"id": "f54acaf0-d21d-4a4c-aa0f-cacec69a7425", "order": 45, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Quality or quantity: What is the best publication strategy? The Editors’ voice", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-09-21T11:15:00.000000", "end_time": "2020-09-21T12:15:00.000000", "rangeorder": 411}
{"id": "97672330-45e7-4afd-b85c-2e50cc8cf0d6", "order": 46, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Basic Science", "session_type": "Mini Oral session", "rangeorder": 500}
{"id": "06627a78-9936-412b-8cde-f630abee52d9", "order": 47, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Breast cancer, early stage", "session_type": "Mini Oral session", "rangeorder": 501}
{"id": "80828a21-e1ef-412f-8bce-7135bdc9d4a0", "order": 48, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Breast cancer, metastatic", "session_type": "Mini Oral session", "rangeorder": 502}
{"id": "f49994db-00ac-48e6-ae77-2abbdbd199e3", "order": 49, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - CNS", "session_type": "Mini Oral session", "rangeorder": 503}
{"id": "9d945a29-d9f8-49db-8d47-667f99faf8eb", "order": 50, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Developmental therapeutics", "session_type": "Mini Oral session", "rangeorder": 504}
{"id": "bfe5a41d-7faf-49ba-b55b-d967a51531e8", "order": 51, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Gastrointestinal tumours, colorectal", "session_type": "Mini Oral session", "rangeorder": 505}
{"id": "d68ff46e-d86f-475c-b371-2df7f5032b1d", "order": 52, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Gastrointestinal tumours, non-colorectal", "session_type": "Mini Oral session", "rangeorder": 506}
{"id": "809128ae-9c4a-4d3a-91d7-20e53a7cc7bb", "order": 53, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Genitourinary tumours, non-prostate", "session_type": "Mini Oral session", "rangeorder": 507}
{"id": "0e03a1ca-511d-47ae-8bc4-534979d8a9d6", "order": 54, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Genitourinary tumours, prostate", "session_type": "Mini Oral session", "rangeorder": 508}
{"id": "fed2c431-0a23-4426-9202-1e0ee73ce2ff", "order": 55, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Gynaecological cancers 1", "session_type": "Mini Oral session", "rangeorder": 509}
{"id": "9525b7c6-3f8d-4c86-a437-9c51d55dd9f7", "order": 56, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Gynaecological cancers 2", "session_type": "Mini Oral session", "rangeorder": 510}
{"id": "5fa22bce-c983-4ade-b9f8-5e81f6b024a5", "order": 57, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Haematological malignancies", "session_type": "Mini Oral session", "rangeorder": 511}
{"id": "9d12d392-f5f7-4fca-9d62-5a6fca5b6bdd", "order": 58, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Head & neck cancer", "session_type": "Mini Oral session", "rangeorder": 600}
{"id": "5373851c-6418-4a19-b046-ed68c490a0d7", "order": 59, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Investigational immunotherapy", "session_type": "Mini Oral session", "rangeorder": 601}
{"id": "92411d66-dc7b-4e7f-93fc-823be72611c5", "order": 60, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Melanoma and other skin tumours", "session_type": "Mini Oral session", "rangeorder": 602}
{"id": "410012ad-3b0d-4b73-833f-39515db7ce68", "order": 61, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - NETs and endocrine tumours", "session_type": "Mini Oral session", "rangeorder": 603}
{"id": "1083f2d9-8fb4-482a-876c-63ed065aa33d", "order": 62, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Non-metastatic NSCLC and other thoracic malignancies", "session_type": "Mini Oral session", "rangeorder": 604}
{"id": "3a199fdc-a748-4905-9841-74a55b67ac1f", "order": 63, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - NSCLC, metastatic", "session_type": "Mini Oral session", "rangeorder": 605}
{"id": "7055e67c-51e4-46a1-aebf-793c0c160112", "order": 64, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Public policy", "session_type": "Mini Oral session", "rangeorder": 606}
{"id": "4961d471-4a98-4907-b9d5-894d49b94812", "order": 65, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Sarcoma", "session_type": "Mini Oral session", "rangeorder": 607}
{"id": "e8b75376-627e-4f49-ad8d-4662aef3c7b7", "order": 66, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - SARS-CoV-2 and cancer 1", "session_type": "Mini Oral session", "rangeorder": 608}
{"id": "18b38ec3-1df2-42d0-8a61-37424e10cea5", "order": 67, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - SARS-CoV-2 and cancer 2", "session_type": "Mini Oral session", "rangeorder": 609}
{"id": "722eb6fc-3fb9-465c-b02d-9289b5f995c7", "order": 68, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Supportive and palliative care", "session_type": "Mini Oral session", "rangeorder": 610}
{"id": "110e7b6e-8060-4b3a-a0cf-3e6e062857c5", "order": 69, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Mini Oral - Translational research", "session_type": "Mini Oral session", "rangeorder": 611}
{"id": "9bdc99eb-596d-4a7c-a2d0-cdf397d18e2a", "order": 70, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology", "session_type": "Industry Satellite Symposium", "rangeorder": 800}
{"id": "72953c89-b46e-43d6-8547-401de7e1b0a1", "order": 71, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology", "session_type": "Industry Satellite Symposium", "rangeorder": 801}
{"id": "90528cca-40cd-490f-ac13-288e62ab9e85", "order": 72, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC", "session_type": "Industry Satellite Symposium", "rangeorder": 802}
{"id": "8e9849b4-69ba-45b1-bb80-3f6cba5503a2", "order": 73, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Pfizer Oncology - Treatment considerations in biomarker-driven NSCLC: Diagnostics and sequencing", "session_type": "Industry Satellite Symposium", "rangeorder": 803}
{"id": "a4c458f5-f90e-49f7-9809-439f8f6e856f", "order": 74, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "MSD - Translating immuno-oncology biomarkers into clinical practice", "session_type": "Industry Satellite Symposium", "rangeorder": 804}
{"id": "8f9edc43-41d1-4fe9-b8ce-ee994c8b878e", "order": 75, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice", "session_type": "Industry Satellite Symposium", "rangeorder": 805}
{"id": "cd38e87e-ad39-4ec3-9c9a-2d3d1f864766", "order": 76, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Illumina - Comprehensive genomic profiling: A new paradigm in oncology", "session_type": "Industry Satellite Symposium", "rangeorder": 806}
{"id": "0cbb3726-2a0b-4750-b5c7-8044e01047a1", "order": 77, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours", "session_type": "Industry Satellite Symposium", "rangeorder": 807}
{"id": "e0318b1e-1be7-4ba4-8fbd-229928c3eaaa", "order": 78, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "MSD - Evolving treatment paradigms for head and neck squamous cell carcinoma (HNSCC)", "session_type": "Industry Satellite Symposium", "rangeorder": 808}
{"id": "82fd33f8-d528-4699-8bf3-8a8ad24b5e46", "order": 79, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3", "session_type": "Industry Satellite Symposium", "rangeorder": 809}
{"id": "bacee142-0f47-4d12-b9c1-d87756d0d0ce", "order": 80, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Pfizer Oncology - The complete picture: Managing breast cancer in the real-world", "session_type": "Industry Satellite Symposium", "rangeorder": 810}
{"id": "ca8ab007-e0a3-48fe-b774-bef524571aa9", "order": 81, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Takeda - Oncogenic drivers in advanced NSCLC: Navigating an evolving landscape to optimize patient outcomes", "session_type": "Industry Satellite Symposium", "rangeorder": 811}
{"id": "19ed0688-e07b-4216-b9c1-58fb051a2c28", "order": 82, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "MSD - Redefining survival expectations in NSCLC", "session_type": "Industry Satellite Symposium", "rangeorder": 900}
{"id": "f85f9e61-bc2e-4378-b2e5-8efe4d0c81b9", "order": 83, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue", "session_type": "Industry Satellite Symposium", "rangeorder": 901}
{"id": "0c103a97-de68-4f0a-9c42-e679ede12265", "order": 84, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Bristol Myers Squibb - Exploring the current and evolving landscape in thoracic cancers", "session_type": "Industry Satellite Symposium", "rangeorder": 902}
{"id": "d6f9d3c5-8f90-473d-a4be-bef67bff26c3", "order": 85, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Servier - Joining efforts beyond first-line management in patients with metastatic pancreatic cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 903}
{"id": "999cbce2-d9bb-4209-a5c0-cbfa1878915c", "order": 86, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Novartis - Transforming treatment in HR+/HER2- advanced breast cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 904}
{"id": "b3eff7d3-5ab5-4c57-8534-c99dd201901e", "order": 87, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Ipsen - The today and tomorrow of systemic treatment for HCC", "session_type": "Industry Satellite Symposium", "rangeorder": 905}
{"id": "dc82a612-9eb5-42b7-bfbe-7ecb3c59b57d", "order": 88, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 906}
{"id": "6bf4e75b-b158-447c-81fb-6272307137c6", "order": 89, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 907}
{"id": "a43e06d6-1e9b-4e95-9fec-db818aeb3dc8", "order": 90, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy", "session_type": "Industry Satellite Symposium", "rangeorder": 908}
{"id": "a3d0046c-26e2-47d5-bbc3-3f7154bbede9", "order": 91, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "10x Genomics - Resolve cancer with single cell and spatial multiomics", "session_type": "Industry Satellite Symposium", "rangeorder": 909}
{"id": "2695c7e2-083a-4b7c-a454-cdad2d09f164", "order": 92, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Boehringer Ingelheim - Focus on NSCLC treatment options", "session_type": "Industry Satellite Symposium", "rangeorder": 910}
{"id": "7c1c6cb3-d2ba-4938-8ed2-914f7d503245", "order": 93, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Merck - From complexity to clarity: Optimizing the mCRC continuum of care (Medical)", "session_type": "Industry Satellite Symposium", "rangeorder": 911}
{"id": "af539111-aee9-4466-b155-a24879d0b447", "order": 94, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Pfizer Oncology - Building a new paradigm in prostate cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 1000}
{"id": "eb0b0a21-faeb-44f9-89ad-ebe876eea95a", "order": 95, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Kite, a Gilead Company - Optimising the patients’ CAR T-cell journey", "session_type": "Industry Satellite Symposium", "rangeorder": 1001}
{"id": "19ec3287-53bd-412c-952f-4850a60c065b", "order": 96, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Janssen - Advanced prostate cancer: How do we move forward in patient management?", "session_type": "Industry Satellite Symposium", "rangeorder": 1002}
{"id": "48eab337-f556-4f43-b801-bc81d63792ca", "order": 97, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "AstraZeneca - Evolving strategies: Managing treatment of early stage and advanced lung cancers", "session_type": "Industry Satellite Symposium", "rangeorder": 1003}
{"id": "d0ebb98f-fbe3-497b-8e70-18900cb864c8", "order": 98, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 1004}
{"id": "92665161-532f-48f4-966d-d24f611f183a", "order": 99, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Merck Pfizer Alliance - 2020: New decade, new treatment choices in GU cancer (Medical)", "session_type": "Industry Satellite Symposium", "rangeorder": 1005}
{"id": "e9851792-8bb4-4809-88e8-c44bcbf3a233", "order": 100, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?", "session_type": "Industry Satellite Symposium", "rangeorder": 1006}
{"id": "60c796cf-7c03-48b7-93d9-e22c8632c77f", "order": 101, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence", "session_type": "Industry Satellite Symposium", "rangeorder": 1007}
{"id": "51f6992b-ed17-400b-8911-9d7517ffccd7", "order": 102, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Astellas - Improving advanced prostate cancer patients’ lives with early treatment intensification", "session_type": "Industry Satellite Symposium", "rangeorder": 1008}
{"id": "92456305-e4b4-4c6d-a6af-23c37aa6f174", "order": 103, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Pierre Fabre - BRAF V600E-mutant mCRC: Spotlight on the patient journey", "session_type": "Industry Satellite Symposium", "rangeorder": 1009}
{"id": "ecc14d1d-5d40-4dbb-9d1d-0120aa493e92", "order": 104, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Amgen (Europe) GmbH - New horizons in the era of precision medicine in lung cancer: KRAS and DLL3 as emerging treatment targets", "session_type": "Industry Satellite Symposium", "rangeorder": 1010}
{"id": "327bfcbe-df29-4a43-82aa-cbec96f7019c", "order": 105, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 1011}
{"id": "51790ae2-c4a8-4d58-9419-6a929195de7a", "order": 106, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days", "session_type": "Industry Satellite Symposium", "rangeorder": 1100}
{"id": "1c61b414-8eab-44c6-b9e0-7772b9df67e3", "order": 107, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Incyte Biosciences International Sàrl - Patient Centricity in Cholangiocarcinoma: A multidisciplinary discussion", "session_type": "Industry Satellite Symposium", "rangeorder": 1101}
{"id": "1240b49d-5e5f-429e-a300-58b1850dfc78", "order": 108, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion", "session_type": "Industry Satellite Symposium", "rangeorder": 1102}
{"id": "48fc1579-ec4f-4433-9df5-a6e9a0d26984", "order": 109, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon", "session_type": "Industry Satellite Symposium", "rangeorder": 1103}
{"id": "3a0b8977-636a-406b-815e-2da21f7cf0eb", "order": 110, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Pierre Fabre - Extending the reach of personalised care in HER2-positive breast cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 1104}
{"id": "eb8af988-5bde-4fdd-aef5-f206b5bbf3d4", "order": 111, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC", "session_type": "Industry Satellite Symposium", "rangeorder": 1105}
{"id": "403fd37a-9557-4ca0-88ca-59fb5400206e", "order": 112, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "MSD - Multiple immunotherapeutic options: Clinical decision making in advanced renal cell carcinoma and urothelial carcinoma", "session_type": "Industry Satellite Symposium", "rangeorder": 1106}
{"id": "7ee08c89-e7d4-4822-9989-31e8cf27a085", "order": 113, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 1107}
{"id": "5930b0d0-f6b2-459e-a1c0-184fae3dff5c", "order": 114, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Samsung Bioepis  - Navigating the Optimized Oncology Treatment Options in Colorectal Cancer, Lung Cancer and Breast Cancer Through Multidisciplinary Discussions", "session_type": "Industry Satellite Symposium", "rangeorder": 1108}
{"id": "fac09ef9-e833-434e-9e5b-5447750debbf", "order": 115, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Bayer - Precision medicine in Real-world clinical practice: Perspectives from a multidisciplinary team", "session_type": "Industry Satellite Symposium", "rangeorder": 1109}
{"id": "ceee6612-d1d3-41cd-8d4d-2eb3542f10ae", "order": 116, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Seattle Genetics - Patient-focused look at tomorrow’s world in HER2+ metastatic breast cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 1110}
{"id": "5422da19-8361-46ff-91f9-60a9862e5f30", "order": 117, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Novartis - Pushing the boundaries: Expanding treatment options for patients with melanoma", "session_type": "Industry Satellite Symposium", "rangeorder": 1111}
{"id": "82e61113-1c98-4d5f-9493-abb422e0245d", "order": 118, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Advanced Accelerator Applications - Elucidate metastatic prostate cancer targets with radioligand therapy and molecular profiling: Advancing precision medicine in prostate cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 1200}
{"id": "1d1247b1-66dd-4d71-b8e1-695b9b5265fe", "order": 119, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?", "session_type": "Industry Satellite Symposium", "rangeorder": 1201}
{"id": "f4156544-e745-4901-86fa-e756cfbce3ff", "order": 120, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "F. Hoffmann-La Roche - Reshaping treatment paradigms for GU cancer patients: Perspectives on PI3K/AKT inhibitors in mCRPC and immunotherapy in urothelial cancer", "session_type": "Industry Satellite Symposium", "rangeorder": 1202}
{"id": "72029276-8fcd-4fb6-9b79-fbba98d80ae3", "order": 121, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice:   Duos, data and decisions", "session_type": "Industry Satellite Symposium", "rangeorder": 1203}
{"id": "e05a2e5c-9b1e-48f5-8bf4-119b2e6ea59e", "order": 122, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "TouchIME - PD1 inhibitors on the horizon for NSCLC: Current knowledge, future possibilities", "session_type": "Industry Satellite Symposium", "rangeorder": 1204}
{"id": "bd581a6e-b9cb-4059-b4bf-fba125b3cb11", "order": 123, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Advanced Accelerator Applications - Optimising NET treatment: The place of radioligand therapy", "session_type": "Industry Satellite Symposium", "rangeorder": 1205}
{"id": "0622fd5e-3b74-42f6-8412-44663fb55784", "order": 124, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma", "session_type": "Industry Satellite Symposium", "rangeorder": 1206}
{"id": "98c3ba75-8d88-466d-b92e-e46ed06ec253", "order": 125, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Merck - The dynamic map of treatment for SCCHN: The optimal pathway for your patient (Commercial)", "session_type": "Industry Satellite Symposium", "rangeorder": 1207}
{"id": "89c4898e-bab5-4fea-a22c-cca1fb541e41", "order": 126, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Servier - Can current treatment strategies for mCRC be further optimized?", "session_type": "Industry Satellite Symposium", "rangeorder": 1208}
{"id": "e165ef71-0437-49aa-9efb-bd753117a97a", "order": 127, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS Satellite - Ipsen: Patient reported outcomes in immuno-oncology in combination with TKI", "session_type": "EONS Satellite", "rangeorder": 1209}
{"id": "8a5557cb-1f7e-46b2-a568-759fe83cb26d", "order": 128, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS Satellite - Merck MSD/Baxter: Digital health and self-management", "session_type": "EONS Satellite", "rangeorder": 1210}
{"id": "62465bc8-3733-40a6-bc49-d8a30ecc8c39", "order": 129, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS Satellite - Eli Lilly/Eisai: Integrative medicine", "session_type": "EONS Satellite", "rangeorder": 1211}
{"id": "e7082b29-1bef-40e9-908d-25dc78a2da4e", "order": 130, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "EONS Satellite - Roche: COVID-19 and cancer nursing", "session_type": "EONS Satellite", "rangeorder": 1300}
{"id": "8931e87d-dcba-49e9-b62f-0c293a479271", "order": 131, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "ESMO Colloquium supported by Eli Lilly and Company: Precision Medicine Implementation in the Clinic: RET as a potential target in cancer treatment", "session_type": "ESMO Colloquium", "rangeorder": 1301}
{"id": "4b030629-e531-4302-90ca-059b452b8807", "order": 132, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "ESMO Colloquium supported by Eli Lilly and Company: Are single agent TKIs still Standard of Care in EGFR mutant Non-Small Cell Lung Cancer or should they be combined with other agents?", "session_type": "ESMO Colloquium", "rangeorder": 1302}
{"id": "4fe12b19-280a-4286-a84a-979e04263a29", "order": 133, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "ESMO Colloquium supported by Eisai: Controversies endometrial cancer: Update on ESMO clinical practice guidelines (CPG) and future treatment direction", "session_type": "ESMO Colloquium", "rangeorder": 1303}
{"id": "4557a186-001d-4243-91bc-67ab79683690", "order": 134, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Linking genetic alterations to dependencies for new cancer therapeutics", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-18T13:45:00.000000", "end_time": "2020-10-18T14:15:00.000000", "rangeorder": 1400}
{"id": "384f702e-4e07-49b9-abba-e1b32ed84dd5", "order": 135, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "The role of ctDNA in colorectal cancer in 2020", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-16T10:30:00.000000", "end_time": "2020-10-16T11:50:00.000000", "rangeorder": 1401}
{"id": "fb31e775-15c9-47e9-9e7f-927cf1ad7055", "order": 136, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Recent updates in treatment strategies", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-18T10:30:00.000000", "end_time": "2020-10-18T11:50:00.000000", "rangeorder": 1402}
{"id": "afd3116a-8655-4bbe-8112-244cfc612146", "order": 137, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Management paradigms for metastatic castration-sensitive prostate cancer", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-16T14:30:00.000000", "end_time": "2020-10-16T15:50:00.000000", "rangeorder": 1403}
{"id": "1d8fb105-8cc6-4c53-88f8-dd8cf9aeb062", "order": 138, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "New drugs in development: What will be approved in 2025?", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-17T16:10:00.000000", "end_time": "2020-10-17T17:30:00.000000", "rangeorder": 1404}
{"id": "9d836241-503c-41c1-9644-9cb3b1ea9b53", "order": 139, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Management of soft tissue sarcomas in 2020: Digital developments and tempting treatments", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-18T12:10:00.000000", "end_time": "2020-10-18T13:30:00.000000", "rangeorder": 1405}
{"id": "70dd21e7-32df-4a5a-bdc7-1bf7e93c6a6f", "order": 140, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Immunotherapy in haematological malignancies", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-16T16:10:00.000000", "end_time": "2020-10-16T17:30:00.000000", "rangeorder": 1406}
{"id": "4a8da3ac-2943-4bf6-bf71-fbba21be4698", "order": 141, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "New horizons in the treatment of pancreatic cancer", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-16T12:10:00.000000", "end_time": "2020-10-16T13:30:00.000000", "rangeorder": 1407}
{"id": "b1a4927f-e7c5-42a5-af79-edbd0bc0155d", "order": 142, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Individualised therapy in advanced urothelial cancer: Prime time?", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-16T12:10:00.000000", "end_time": "2020-10-16T13:30:00.000000", "rangeorder": 1408}
{"id": "ef997f7a-29a7-4296-9ee3-1b7c3ede49c5", "order": 143, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Advances in mesothelioma", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-16T10:30:00.000000", "end_time": "2020-10-16T11:50:00.000000", "rangeorder": 1409}
{"id": "3ddfea95-0ab1-4a6a-b59e-62f8054e5706", "order": 144, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Preclinical models for unanswered clinical questions", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-18T16:10:00.000000", "end_time": "2020-10-18T17:30:00.000000", "rangeorder": 1410}
{"id": "c3102757-fa90-4edb-bf37-5150ae8a37eb", "order": 145, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Peptide Receptor Radionuclide Therapy (PRRT) integration with other therapies", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-18T10:30:00.000000", "end_time": "2020-10-18T11:50:00.000000", "rangeorder": 1411}
{"id": "e86503dc-be8c-4d51-aa17-a4506a5b4f66", "order": 146, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "CNS metastasis: Optimising local therapy, improving systemic control", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-16T14:30:00.000000", "end_time": "2020-10-16T15:50:00.000000", "rangeorder": 1500}
{"id": "298cf63d-308b-4da1-8b37-8dee6867e677", "order": 147, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Immunometabolism as target for immunotherapy of cancer", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-16T14:30:00.000000", "end_time": "2020-10-16T15:50:00.000000", "rangeorder": 1501}
{"id": "f70242a0-4eff-4748-9a06-bdf7a55adca4", "order": 148, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Targeted treatment in 2020", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-17T14:30:00.000000", "end_time": "2020-10-17T15:50:00.000000", "rangeorder": 1502}
{"id": "e6da1f1c-bf08-4c7f-972e-5f9555b11f94", "order": 149, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Treatment of upper GI tumours in the time of precision oncology", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-18T14:30:00.000000", "end_time": "2020-10-18T15:50:00.000000", "rangeorder": 1503}
{"id": "2e7fb8e8-3c04-4b28-b42e-44a5040ddd11", "order": 150, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-18T16:10:00.000000", "end_time": "2020-10-18T17:30:00.000000", "rangeorder": 1504}
{"id": "8aec8c0e-4b1e-4ca1-951b-824eacb80625", "order": 151, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Blood-brain barrier", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-18T10:30:00.000000", "end_time": "2020-10-18T11:50:00.000000", "rangeorder": 1505}
{"id": "fec65277-dc0f-4561-9fa8-36bb32ffd373", "order": 152, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Future needs and techniques in oncology research", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-17T14:30:00.000000", "end_time": "2020-10-17T15:50:00.000000", "rangeorder": 1506}
{"id": "28e3ff49-7f21-4fc1-8725-be87da686dc2", "order": 153, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "The microbiome and its impact on molecular treatment decisions in cancer", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-16T13:45:00.000000", "end_time": "2020-10-16T14:15:00.000000", "rangeorder": 1507}
{"id": "11e38ff6-1530-4a68-a5cd-bfb461fc46eb", "order": 154, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "First-line therapy in ovarian cancer: Where do we stand and how do we move forwards?", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-17T10:30:00.000000", "end_time": "2020-10-17T11:50:00.000000", "rangeorder": 1508}
{"id": "afb6dcd0-286d-4c2e-acfd-c06725422c85", "order": 155, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Where are we and where are we going in early breast cancer? Better approaches to cure more patients", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-16T12:10:00.000000", "end_time": "2020-10-16T13:30:00.000000", "rangeorder": 1509}
{"id": "411cc889-eed2-432c-be72-f7112687cb5c", "order": 156, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Bone and soft tissue tumours in young adult patients", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-16T12:10:00.000000", "end_time": "2020-10-16T13:30:00.000000", "rangeorder": 1510}
{"id": "76844e67-a7aa-4fd8-b297-0276cd645072", "order": 157, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Immunotherapy in colorectal cancer: Present and future", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-17T14:30:00.000000", "end_time": "2020-10-17T15:50:00.000000", "rangeorder": 1511}
{"id": "7f6be5b6-0885-4cf2-81ea-7a880bfda86c", "order": 158, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "What other immunotherapy options are there in recurrent metastatic disease?", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-17T12:10:00.000000", "end_time": "2020-10-17T13:30:00.000000", "rangeorder": 1600}
{"id": "487a932d-1cb2-4300-a213-b1ffb9b2419e", "order": 159, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Tumour heterogeneity and its influence on cancer and immune therapy responses", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-17T12:10:00.000000", "end_time": "2020-10-17T13:30:00.000000", "rangeorder": 1601}
{"id": "bf159807-8c28-42ba-9ef2-175da2af134b", "order": 160, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Dissecting the heterogeneity of breast cancer", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-16T10:30:00.000000", "end_time": "2020-10-16T11:50:00.000000", "rangeorder": 1602}
{"id": "5e622078-0b92-40ca-b12b-61069557a139", "order": 161, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Maximising the quality of short life", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-16T10:30:00.000000", "end_time": "2020-10-16T11:50:00.000000", "rangeorder": 1603}
{"id": "4d3deaeb-6c9c-461e-9ca7-9db4424fcd71", "order": 162, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Applications of artificial intelligence (AI) in oncology drug development", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-18T10:30:00.000000", "end_time": "2020-10-18T11:50:00.000000", "rangeorder": 1604}
{"id": "fbe1a297-538b-4f35-9b04-2050c3c9d267", "order": 163, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Present and future of cancer immunotherapy", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-17T13:45:00.000000", "end_time": "2020-10-17T14:15:00.000000", "rangeorder": 1605}
{"id": "a3f6a172-720a-43b0-a2dc-21132f89792c", "order": 164, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-17T14:30:00.000000", "end_time": "2020-10-17T15:50:00.000000", "rangeorder": 1606}
{"id": "bf47fb87-8662-4cd7-806e-f3433b695fb3", "order": 165, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Targeting DNA damage response pathways in cancer", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-18T12:10:00.000000", "end_time": "2020-10-18T13:30:00.000000", "rangeorder": 1607}
{"id": "d71593bc-b21a-4d12-a0db-9350488a08f9", "order": 166, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "What to do with patients who attend appointments with a next generation sequencing (NGS) platform dataset", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-18T12:10:00.000000", "end_time": "2020-10-18T13:30:00.000000", "rangeorder": 1608}
{"id": "061040a7-e1b4-4cd2-bfa1-7a58a69b3c57", "order": 167, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Future directions of supportive and palliative care in a changing landscape", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-16T16:10:00.000000", "end_time": "2020-10-16T17:30:00.000000", "rangeorder": 1609}
{"id": "07764097-a45b-400f-b971-ddc1dd9f6580", "order": 168, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Breakthroughs in immunotherapy for non-metastatic NSCLC", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-18T16:10:00.000000", "end_time": "2020-10-18T17:30:00.000000", "rangeorder": 1610}
{"id": "e361c5e9-b20d-4b3e-870f-f297438092fd", "order": 169, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "GIST, a single acronym for multiple diseases and paradigms: Time to reset", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-16T14:30:00.000000", "end_time": "2020-10-16T15:50:00.000000", "rangeorder": 1611}
{"id": "e318b589-33b4-4c4d-afda-ee6104f1463a", "order": 170, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Unlocking precision medicine for metastatic prostate cancer", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-18T16:10:00.000000", "end_time": "2020-10-18T17:30:00.000000", "rangeorder": 1700}
{"id": "b9c0d963-ace9-4804-ac15-de001d799092", "order": 171, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "The opioid crisis", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-17T10:30:00.000000", "end_time": "2020-10-17T11:50:00.000000", "rangeorder": 1701}
{"id": "6b3421ca-1b80-4f86-95e4-17bdcc8c68d4", "order": 172, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-17T16:10:00.000000", "end_time": "2020-10-17T17:30:00.000000", "rangeorder": 1702}
{"id": "28b35582-0906-49d9-ad4f-aad396b560f9", "order": 173, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Myelodysplastic syndromes in 2020", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-17T10:30:00.000000", "end_time": "2020-10-17T11:50:00.000000", "rangeorder": 1703}
{"id": "2de59737-4898-477d-987a-f49e866a4fca", "order": 174, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Maximising the benefit of immuno-oncology", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-17T16:10:00.000000", "end_time": "2020-10-17T17:30:00.000000", "rangeorder": 1704}
{"id": "fcdc788b-b2e0-4698-95db-07e35bab2b95", "order": 175, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Are we ready for another big step in kidney and bladder cancer?", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-18T12:10:00.000000", "end_time": "2020-10-18T13:30:00.000000", "rangeorder": 1705}
{"id": "91811043-0728-4318-9926-04d8762d9aaa", "order": 176, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "The microenvironment of cancer", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-18T14:30:00.000000", "end_time": "2020-10-18T15:50:00.000000", "rangeorder": 1706}
{"id": "b90481d0-96c4-49c8-8674-a4b61c057f5b", "order": 177, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Abscopal and anenestic effect: Local immunotherapies with systemic potential", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-18T14:30:00.000000", "end_time": "2020-10-18T15:50:00.000000", "rangeorder": 1707}
{"id": "ea8d1987-d612-4398-b84c-fc7d707dc893", "order": 178, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Lung cancer diagnosis in 2020: State of the art", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-16T16:10:00.000000", "end_time": "2020-10-16T17:30:00.000000", "rangeorder": 1708}
{"id": "a47c7549-e5d8-4a2b-9415-5c1b14f07fd4", "order": 179, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Cancer evolution", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-16T16:10:00.000000", "end_time": "2020-10-16T17:30:00.000000", "rangeorder": 1709}
{"id": "576f4ced-fbd5-4ab1-b5c6-3cf35becca08", "order": 180, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Classification and management of GEP NEN patients", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-16T14:30:00.000000", "end_time": "2020-10-16T15:50:00.000000", "rangeorder": 1710}
{"id": "458d8bd1-a7c7-4572-84e5-c14023af247f", "order": 181, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Checkpoint inhibitors and beyond in gynaecological cancers", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-18T10:30:00.000000", "end_time": "2020-10-18T11:50:00.000000", "rangeorder": 1711}
{"id": "d2cf943b-4db1-4c5f-af9f-79065292e953", "order": 182, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "How to implement screening for lung cancer", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-18T14:30:00.000000", "end_time": "2020-10-18T15:50:00.000000", "rangeorder": 1800}
{"id": "1e188668-ecd8-4790-9886-7aeccc62ba0e", "order": 183, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Survivorship is not survivorship without quality of life", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-17T10:30:00.000000", "end_time": "2020-10-17T11:50:00.000000", "rangeorder": 1801}
{"id": "34dd92b5-7e67-4e3e-af9c-4e00e541b315", "order": 184, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "How patient advocates can improve equal access to care and services across Europe and beyond: Concrete examples of success stories", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-18T16:10:00.000000", "end_time": "2020-10-18T17:30:00.000000", "rangeorder": 1802}
{"id": "f2d5ad74-25d2-40b8-b41d-4990c86621aa", "order": 185, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "The cancer journey: The importance of getting the right physical and mental support", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-18T12:10:00.000000", "end_time": "2020-10-18T13:30:00.000000", "rangeorder": 1803}
{"id": "221c4ced-c47d-4350-86cc-58a8a3b774f4", "order": 186, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Precision medicine: Hopes and hypes", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-17T12:10:00.000000", "end_time": "2020-10-17T13:30:00.000000", "rangeorder": 1804}
{"id": "d47a5711-77b9-4803-8300-93298b3ba6f2", "order": 187, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Research in AYA with cancer: Age-specific challenges and ways forward", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-17T14:30:00.000000", "end_time": "2020-10-17T15:50:00.000000", "rangeorder": 1805}
{"id": "67abb90d-b2ef-4187-8bd0-b52ae55f3f3a", "order": 188, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Challenges in managing an aging population of patients with cancer (in collaboration with SIOG)", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-17T10:30:00.000000", "end_time": "2020-10-17T11:50:00.000000", "rangeorder": 1806}
{"id": "e2522e58-da3d-47db-9fd5-9142990745ff", "order": 189, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Established and new treatments, old and new toxicities (in collaboration with MASCC)", "session_type": "Channel 3", "location": "Channel 3", "start_time": "2020-10-17T12:10:00.000000", "end_time": "2020-10-17T13:30:00.000000", "rangeorder": 1807}
{"id": "e54fe27a-f2c7-47b8-aa4e-055b73681c72", "order": 190, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "The WHO Report on Cancer: What cancer policies are missing in your country? (in collaboration with WHO)", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-16T12:10:00.000000", "end_time": "2020-10-16T13:30:00.000000", "rangeorder": 1808}
{"id": "2bc678ae-e4f2-42a9-af9e-971739800345", "order": 191, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-17T16:10:00.000000", "end_time": "2020-10-17T17:30:00.000000", "rangeorder": 1809}
{"id": "b6a80579-4f9f-4525-a1f6-18df0cc80b73", "order": 192, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Cancer prevention: Action time to say NO to tobacco", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-16T16:10:00.000000", "end_time": "2020-10-16T17:30:00.000000", "rangeorder": 1810}
{"id": "d10308a7-3834-40d6-a45f-97f88c79d26a", "order": 193, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "How to run clinical trials and survive your CRO", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-17T12:10:00.000000", "end_time": "2020-10-17T13:30:00.000000", "rangeorder": 1811}
{"id": "a99555c2-166e-4ad8-b40a-49d7350b242b", "order": 194, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Unleashing the potential of artificial intelligence (AI) in oncology: Time to go from a conceptual dream to real actions", "session_type": "Channel 5", "location": "Channel 5", "start_time": "2020-10-16T10:30:00.000000", "end_time": "2020-10-16T11:50:00.000000", "rangeorder": 1900}
{"id": "b3bfb5d8-a56c-4627-b3f7-a6a29063ea3c", "order": 195, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "How can we reduce cancer numbers?  (in collaboration with ASCO)", "session_type": "Channel 4", "location": "Channel 4", "start_time": "2020-10-17T16:10:00.000000", "end_time": "2020-10-17T17:30:00.000000", "rangeorder": 1901}
{"id": "47ff16ac-6dff-449e-ba6c-ef1ba9be1de9", "order": 196, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Nutritional management of cancer patients in daily practice", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-12T13:00:00.000000", "end_time": "2020-10-12T14:30:00.000000", "rangeorder": 1902}
{"id": "0d8c21b5-e1de-4232-b98b-123b19f2ed36", "order": 197, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Oligometastatic disease: Does it exist? How can I treat it? Locally, systemically or both", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-13T13:00:00.000000", "end_time": "2020-10-13T14:30:00.000000", "rangeorder": 1903}
{"id": "32728e40-644b-4e12-8043-9b9abb7ebffb", "order": 198, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Which patient belongs where for systemic treatment? How to divide tasks between academic and regional hospitals", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-14T13:00:00.000000", "end_time": "2020-10-14T14:30:00.000000", "rangeorder": 1904}
{"id": "2c617efc-7a0e-4dc8-a247-36eb83a22654", "order": 199, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Let it bleed? Specific situations in cancer patients and thrombo-embolism", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-15T13:00:00.000000", "end_time": "2020-10-15T14:10:00.000000", "rangeorder": 1905}
{"id": "2fea3e0a-8f40-42db-b36b-4bdc47352ac8", "order": 200, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "ESMO Award", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-12T15:00:00.000000", "end_time": "2020-10-12T15:30:00.000000", "rangeorder": 1906}
{"id": "50c69af5-d5e0-4678-a4fa-c6a076881635", "order": 201, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "ESMO Translational Research Award", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-13T15:00:00.000000", "end_time": "2020-10-13T15:30:00.000000", "rangeorder": 1907}
{"id": "5d82c965-907e-4700-ae6e-699f3f791308", "order": 202, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "ESMO Women for Oncology Award", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-14T15:00:00.000000", "end_time": "2020-10-14T15:30:00.000000", "rangeorder": 1908}
{"id": "8b105abc-2dc2-4358-8927-e7dcbb22930f", "order": 203, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "ESMO Lifetime Achievement Award", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-15T15:00:00.000000", "end_time": "2020-10-15T15:30:00.000000", "rangeorder": 1909}
{"id": "618daeb2-ad87-4d97-8697-01c26d71b497", "order": 204, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Biggest challenges facing young oncologists in 2030: How to address the next generation of anticancer treatments", "session_type": "Channel 2", "location": "Channel 2", "start_time": "2020-10-18T14:30:00.000000", "end_time": "2020-10-18T15:50:00.000000", "rangeorder": 1910}
{"id": "48e60ea3-c9e2-428b-95aa-f3a7da3f795a", "order": 205, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "Opening session: Education Weekend", "session_type": "Channel 1", "location": "Channel 1", "start_time": "2020-10-16T09:35:00.000000", "end_time": "2020-10-16T10:15:00.000000", "rangeorder": 1911}
{"id": "35724013-f88c-4a5c-869f-0cb5b397164e", "order": 206, "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "title": "e-posters session", "session_type": "e-posters session", "rangeorder": 1010000}
